Dr. Rajen Mody, MD, MS
Claim this profileC S Mott Children's Hospital
Expert in Neuroblastoma
Expert in Tumors
50 reported clinical trials
82 drugs studied
About Rajen Mody, MD, MS
Education:
- Earned an MD (Doctor of Medicine).
- Holds an MS (Master of Science).
Experience:
- Serves as Division Chief and Fellowship Program Director at the Pediatric Hematology/Oncology Fellowship Program, C.S. Mott Children's Hospital, University of Michigan.
- Recognized for expertise in pediatric hematology and oncology, covering both non-malignant and malignant disorders.
- Instrumental in developing a fellowship program aimed at nurturing future scientific investigators in pediatric hematology.
- Engages in cutting-edge research and clinical care, including precision medicine and genomic sequencing, for children.
Area of expertise
1Neuroblastoma
Global LeaderMYC positive
Stage IV
MYC negative
2Tumors
Global LeaderStage IV
NTRK1 positive
NTRK positive
Affiliated Hospitals
Clinical Trials Rajen Mody, MD, MS is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Rajen Mody, MD, MS
Clinical Trial Related7 years of experience running clinical trials · Led 50 trials as a Principal Investigator · 17 Active Clinical TrialsTreatments Rajen Mody, MD, MS has experience with
- Dinutuximab
- Cyclophosphamide
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Ramucirumab
- Larotrectinib
Breakdown of trials Rajen Mody, MD, MS has run
Neuroblastoma
Tumors
Lymphoma
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rajen Mody, MD, MS specialize in?
Rajen Mody, MD, MS focuses on Neuroblastoma and Tumors. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are Stage IV.
Is Rajen Mody, MD, MS currently recruiting for clinical trials?
Yes, Rajen Mody, MD, MS is currently recruiting for 11 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Rajen Mody, MD, MS has studied deeply?
Yes, Rajen Mody, MD, MS has studied treatments such as Dinutuximab, Cyclophosphamide, Cytology Specimen Collection Procedure.
What is the best way to schedule an appointment with Rajen Mody, MD, MS?
Apply for one of the trials that Rajen Mody, MD, MS is conducting.
What is the office address of Rajen Mody, MD, MS?
The office of Rajen Mody, MD, MS is located at: C S Mott Children's Hospital, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the C S Mott Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.